The investigational IL-17A inhibitor izokibep was found to induce clear clinical responses in people with moderate to severe ...

The Phase 2 clinical trial is an open-label, pilot efficacy study and exploratory evaluation of the systemic bioavailability ...

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Yufei Liu, MD, PhD, discussed the importance of careful data interpretation to accurately assess the efficacy of new ...

KaliVir Immunotherapeutics has dosed the first subject in a Phase I/Ib clinical trial for its new oncolytic immunotherapy, ...

including the sought-after PG Diploma in Clinical Research, ensure that our students are well-prepared to drive the complex terrain of clinical trials. In this article, we will decode the phases of ...

Precision BioSciences Submits First Clinical Trial Applications to Initiate Phase 1 Trial for PBGENE-HBV for the Treatment of Chronic Hepatitis B ...

Nerandomilast demonstrated it was able to outperform a placebo at improving lung function in IPF or preventing its decline ...

Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy's Laboratories has announced the Phase 1 results for Ribrecabtagene autoleucel (DRL-1801) from the SWASTH study - India's first trial for a ...

SetPoint plans to launch a trial of its implant device, stimulating the vagus nerve to promote myelin repair, next year in ...